4
Changes in Ownership
BIODESIX INC Filed Acc 0000905148-23-000511
Options or other derivatives
- Chief Commercial Officer acquired 68,218 shares (grant or award)
- Chief Commercial Officer returned 56,654 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| O'Kane Kieran Chief Commercial Officer | 2021-02-23 | Grant or award · Stock Options (Right to buy) | +25,599 | 25,599 | D: show line 1 in the form | |||||
| O'Kane Kieran Chief Commercial Officer | 2021-02-23 | Grant or award · Stock Options (Right to buy) | +31,055 | 31,055 | D: show line 2 in the form | |||||
| O'Kane Kieran Chief Commercial Officer | 2023-07-24 | Returned to the company · Stock Options (Right to buy) | −25,599 | 0 | D: show line 3 in the form | |||||
| O'Kane Kieran Chief Commercial Officer | 2023-07-24 | Returned to the company · Stock Options (Right to buy) | −31,055 | 0 | D: show line 4 in the form | |||||
| O'Kane Kieran Chief Commercial Officer | 2023-07-24 | Grant or award · Stock Options (Right to buy) | +11,564 | 11,564 | D: show line 5 in the form |
Loading xslF345X05/form4.xml…